Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
$0.00
$0.00
▼
$0.00
$4K0.858,000 shs53 shs
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$0.00
$0.02
$0.75
▼
$1.65
$13K-0.88708,132 shs89 shs
UPHL
UpHealth
$0.00
$0.00
$0.00
▼
$0.01
$6K0.292,163 shs225 shs
VRAYQ
ViewRay
$0.00
$0.00
▼
$0.00
$16K0.7719,400 shs5,225 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00%0.00%0.00%0.00%0.00%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.00%+25.00%-97.61%-98.75%-99.29%
UPHL
UpHealth
0.00%0.00%+200.00%+200.00%+50.00%
VRAYQ
ViewRay
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
$0.00
$0.00
▼
$0.00
$4K0.858,000 shs53 shs
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$0.00
$0.02
$0.75
▼
$1.65
$13K-0.88708,132 shs89 shs
UPHL
UpHealth
$0.00
$0.00
$0.00
▼
$0.01
$6K0.292,163 shs225 shs
VRAYQ
ViewRay
$0.00
$0.00
▼
$0.00
$16K0.7719,400 shs5,225 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00%0.00%0.00%0.00%0.00%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.00%+25.00%-97.61%-98.75%-99.29%
UPHL
UpHealth
0.00%0.00%+200.00%+200.00%+50.00%
VRAYQ
ViewRay
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00
N/AN/AN/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.00
N/AN/AN/A
UPHL
UpHealth
0.00
N/AN/AN/A
VRAYQ
ViewRay
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$15.22M0.00N/AN/A$0.69 per share0.00
UPHL
UpHealth
$130M0.00N/AN/A$3.10 per share0.00
VRAYQ
ViewRay
$102.21M0.00N/AN/AN/ANaN
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
-$39.76M-$0.39N/AN/AN/AN/AN/AN/AN/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
-$10.54M-$0.27N/AN/AN/A-75.40%-52.17%-34.51%N/A
UPHL
UpHealth
-$56.42M$1.98N/AN/AN/AN/AN/AN/AN/A
VRAYQ
ViewRay
-$107.33MN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
N/AN/AN/AN/AN/A
UPHL
UpHealth
N/AN/AN/AN/AN/A
VRAYQ
ViewRay
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.01
1.27
1.27
UPHL
UpHealth
N/AN/AN/A
VRAYQ
ViewRay
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
34.00%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
24.27%
UPHL
UpHealth
56.10%
VRAYQ
ViewRay
15.47%

Insider Ownership

CompanyInsider Ownership
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
51.40%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
10.00%
UPHL
UpHealth
34.24%
VRAYQ
ViewRay
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
4040.58 million24.23 millionNo Data
IMAC Holdings, Inc. stock logo
IMAC
IMAC
10626.49 million23.84 millionNot Optionable
UPHL
UpHealth
1,75018.93 million12.45 millionNo Data
VRAYQ
ViewRay
300164.74 million178.82 millionNo Data

Recent News About These Companies

ViewRay Inc.
July 3, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/vrayq/financials

New MarketBeat Followers Over Time

Media Sentiment Over Time

Better Therapeutics stock logo

Better Therapeutics NASDAQ:BTTX

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

IMAC stock logo

IMAC NASDAQ:IMAC

$0.0005 0.00 (0.00%)
As of 08/14/2026

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

UpHealth NYSE:UPHL

$0.0003 0.00 (0.00%)
As of 08/14/2026 09:55 AM Eastern

UpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida.

ViewRay NASDAQ:VRAYQ

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. On July 16, 2023, ViewRay, Inc., alongwith its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay , Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas